↓ Skip to main content

Haloperidol dose for the acute phase of schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, August 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

twitter
15 tweeters
f1000
1 research highlight platform

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
91 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Haloperidol dose for the acute phase of schizophrenia
Published in
Cochrane database of systematic reviews, August 2013
DOI 10.1002/14651858.cd001951.pub2
Pubmed ID
Authors

Lorna Donnelly, John Rathbone, Clive E Adams

Abstract

Haloperidol is a benchmark, accessible antipsychotic drug against which the effects of newer treatments are gauged.

Twitter Demographics

The data shown below were collected from the profiles of 15 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 91 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 91 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 23 25%
Researcher 14 15%
Student > Ph. D. Student 12 13%
Unspecified 9 10%
Student > Bachelor 7 8%
Other 26 29%
Readers by discipline Count As %
Medicine and Dentistry 31 34%
Psychology 15 16%
Unspecified 13 14%
Nursing and Health Professions 9 10%
Social Sciences 7 8%
Other 16 18%

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 January 2016.
All research outputs
#1,470,754
of 12,527,219 outputs
Outputs from Cochrane database of systematic reviews
#3,791
of 8,923 outputs
Outputs of similar age
#20,665
of 155,917 outputs
Outputs of similar age from Cochrane database of systematic reviews
#48
of 125 outputs
Altmetric has tracked 12,527,219 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one has gotten more attention than average, scoring higher than 63% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 155,917 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 125 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.